Moneycontrol Be a Pro
Get App
you are here: HomeNewsBusiness
Last Updated : Jun 17, 2019 12:39 PM IST | Source: PTI

USFDA makes 2 observations for Caplin's sterile injectable site in Chennai

The US Food and Drug Administration (USFDA) has completed inspection of Caplin Steriles Ltd's site at Gummidipoondi in Tamil Nadu, between June 6-14, 2019.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Caplin Point Laboratories on Monday said the US health regulator has made two observations after completion of inspection at its subsidiary's sterile injectable site in Tamil Nadu.

The US Food and Drug Administration (USFDA) has completed inspection of Caplin Steriles Ltd's site at Gummidipoondi in Tamil Nadu, between June 6-14, 2019.

At the end of this scheduled Good Manufacturing Practice (GMP) inspection, there were only two observations, Caplin Point Laboratories said in a BSE filing.

Close

Caplin Point Laboratories said it believes these observations are procedural in nature and corrective and "preventive actions for these observations will be presented to the USFDA shortly".

"The observations made were not repeat observations or related to data integrity. This was the third USFDA audit at the plant since 2016," the company added.

Caplin Point Laboratories Chairman C C Paarthipan said: "our primary focus is to ensure integrity and maintain transparency in our quality systems, and we're pleased with the result of yet another successful audit."

Shares of Caplin Point Laboratories were trading 0.64 per cent lower at Rs 420 apiece on BSE.

Get access to India's fastest growing financial subscriptions service Moneycontrol Pro for as little as Rs 599 for first year. Use the code "GETPRO". Moneycontrol Pro offers you all the information you need for wealth creation including actionable investment ideas, independent research and insights & analysis For more information, check out the Moneycontrol website or mobile app.
First Published on Jun 17, 2019 12:36 pm
Loading...
Sections
Follow us on
Available On